Evaluation of Voice Therapy After Type I, II, and V Cordectomy for Early-Stage Laryngeal Cancer Using Subjective Voice Quality Assessment Tools
Annals of Otology, Rhinology & Laryngology · 2024
DOI: 10.1177/00034894241255828 ↗Kurz gefasst
Leserbrief in der Zeitschrift Annals of Otology, Rhinology & Laryngology, 2024. Verfasst von Giorgos Sideris und 3 weiteren Autor:innen. Beteiligte Einrichtung: National & Kapodistrian University of Athens, School of Medicine, 2nd Otolaryngology Department, Voice, Speech and Swallowing Disorders Treatment Uni…. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Voice Quality, Vocal Cords. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- National & Kapodistrian University of Athens, School of Medicine, 2nd Otolaryngology Department, Voice, Speech and Swallowing Disorders Treatment Unit, "Attikon" University Hospital, Athens, Greece.
ORCID-Profile: Giorgos Sideris, Evangelos Panagoulis, Alexander Delides
Zitieren
APA
Sideris, G., Papadopoulou, E., Panagoulis, E., & Delides, A. (2024). Evaluation of Voice Therapy After Type I, II, and V Cordectomy for Early-Stage Laryngeal Cancer Using Subjective Voice Quality Assessment Tools. Annals of Otology, Rhinology & Laryngology. https://doi.org/10.1177/00034894241255828
Vancouver
Sideris G, Papadopoulou E, Panagoulis E, Delides A. Evaluation of Voice Therapy After Type I, II, and V Cordectomy for Early-Stage Laryngeal Cancer Using Subjective Voice Quality Assessment Tools. Annals of Otology, Rhinology & Laryngology. 2024. doi:10.1177/00034894241255828
BibTeX
@article{Sideris2024,
author = {Sideris, Giorgos and Papadopoulou, Elisavet and Panagoulis, Evangelos and Delides, Alexander},
title = {Evaluation of Voice Therapy After Type I, II, and V Cordectomy for Early-Stage Laryngeal Cancer Using Subjective Voice Quality Assessment Tools},
journal = {Annals of Otology, Rhinology & Laryngology},
year = {2024},
doi = {10.1177/00034894241255828}
}
EUVIMED